Fears NHS weight loss jab could be harmful to those vulnerable to eating disorders
A newly approved weight loss jab should be used with caution as it could be harmful to those vulnerable to eating disorders, doctors have warned.
Thousands struggling with obesity could be prescribed Wegovy, or semaglutide, which scientists have described as a “game changer”, after the National Institute for Health and Care Excellence (NICE) approved its use.
However, eating disorder experts have warned the NHS to proceed with caution in prescribing the drug, with one GP accusing NICE of being “absolutely reckless” in approving it.
The drug was approved on Wednesday for use in adults who have at least one weight-related condition, such as type 2 diabetes, high blood pressure, high cholesterol sleep apnoea and heart disease, and a body mass index score of at least 35. It can only be prescribed to those undergoing weight management treatment.
Source: The Independent, 8 March 2023